Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SNX-1012 for Ulcerative Oral Mucositis in Breast or Lung Cancer
NCT00385515Phase 2Completed
- Start
- Jun 2006
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial in oral mucositis (OM) comparing SNX-1012 with Placebo (2 arms). Primary endpoint: Duration of Ulcerative Oral Mucositis at 10 days. Started Jun 2006; status: completed.
02
Drugs
meclocycline
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT00385515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00385515.